G01N 2800/101
Diffuse connective tissue disease
Official title: Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
G01N2800/101 (Diffuse connective tissue disease) appears on 497 US grants and 891 published applications in this corpus.
Search patents in G01N- Granted patents
- 497
- Published applications
- 891
- Assignees
- 560
- Inventors
- 1,933
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 5 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 10 | 0 |
| 1995 | 7 | 0 |
| 1996 | 7 | 0 |
| 1997 | 12 | 0 |
| 1998 | 9 | 0 |
| 1999 | 11 | 0 |
| 2000 | 12 | 0 |
| 2001 | 5 | 1 |
| 2002 | 3 | 3 |
| 2003 | 11 | 17 |
| 2004 | 3 | 15 |
| 2005 | 9 | 21 |
| 2006 | 9 | 30 |
| 2007 | 6 | 30 |
| 2008 | 5 | 33 |
| 2009 | 11 | 34 |
| 2010 | 16 | 35 |
| 2011 | 18 | 59 |
| 2012 | 13 | 42 |
| 2013 | 16 | 45 |
| 2014 | 22 | 48 |
| 2015 | 18 | 42 |
| 2016 | 17 | 53 |
| 2017 | 24 | 53 |
| 2018 | 28 | 43 |
| 2019 | 23 | 46 |
| 2020 | 28 | 48 |
| 2021 | 19 | 36 |
| 2022 | 22 | 43 |
| 2023 | 18 | 35 |
| 2024 | 20 | 33 |
| 2025 | 17 | 26 |
| 2026 | 10 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for detection of pathogenic antiphospholipid antibodies and for identification of inhibitors29 Sep 2026US 12,748,111 B2The Scripps Research Institute
- Antibody tests for identifying Ro negative Sjogren's Syndrome and use as biomarkers for dysregulated B cell responses, B cell lymphoma, tissue fibrosis and salivary gland dysfunction15 Sep 2026US 12,736,533 B2Oklahoma Medical Research Foundation
- Methods for predicting patient response to DMARDs14 Jul 2026US 12,681,015 B2Queen Mary University of London
- Ovarian cancer organoid culture16 Jun 2026US 12,655,394 B2Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Biomarkers of early osteoarthritis16 Jun 2026US 12,656,343 B2CD Diagnostics, Inc.
- Staining kit and method for assessing likelihood of rheumatoid arthritis disease risk using the same1 Oct 2026US 2026/0298923 A1
- Anti-Vimentin Antibodies are Associated With Higher Severity of Sjogren's Syndrome3 Sep 2026US 2026/0259208 A1
- Genetic testing for early detection of autoimmune diseases6 Aug 2026US 2026/0226547 A1New York Society for the Relief of the Ruptured and Crippled, maintaining the Hospital for Special S
- Systems and methods for molecular endotyping of rheumatoid arthritis30 Jul 2026US 2026/0221227 A1AMPEL BioSolutions, LLC
- Method for selecting stem cells with enhanced cartilage differentiation capability and cell therapy product comprising same23 Jul 2026US 2026/0209709 A1
Most cited
By later US patents
- Method for identifying T cells disease involved in autoimmune disease97US 5,298,396 ANational Jewish Center for Immunology and Respiratory Medicine · 1994
- Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-193US 7,598,228 B2Asubio Pharma Co., Ltd. · 2009
- Method for diagnosing rheumatoid arthritis64US 5,395,753 ATheratech, Inc. · 1995
- Method for identifying T cells involved in autoimmune disease62US 5,776,708 ANational Jewish Center for Immunology and Respiratory Medicine · 1998
- Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof57US 4,886,743 ACalifornia Institute of Technology · 1989